Radiation dermatitis is the skin damage that develops during or after radiation therapy, and it affects the vast majority of people who undergo the treatment. Roughly 85% to 95% of radiotherapy patients develop some degree of acute skin reaction, ranging from mild redness to painful, weeping wounds.1PubMed. Radiation-Induced Skin Injury: Mechanisms, Clinical Manifestations, and Management The condition is sometimes dismissed as an unavoidable nuisance of cancer care, but for up to one in five patients, it escalates into a severe reaction that can interrupt treatment, slow healing, and significantly erode quality of life.
What Happens to the Skin During Radiotherapy
Radiation works by damaging the DNA inside rapidly dividing cells. Cancer cells are the intended target, but the skin sitting in the beam path takes collateral damage. The stem and progenitor cells in the deepest layer of the epidermis are especially vulnerable because they are constantly dividing to replenish the skin’s outer surface. When radiation cripples their ability to divide, the normal cycle of skin renewal slows or stalls.2PubMed Central. Radiation Dermatitis: Radiation-Induced Effects on the Structural and Immunological Barrier Function of the Epidermis On top of this, the radiation triggers a cascade of reactive oxygen species and pro-inflammatory signaling molecules, essentially putting the immune system on high alert in the irradiated area.3PubMed. Radiation-Induced Skin Injury: Mechanisms, Clinical Manifestations, and Management Research in animal models has shown that specific immune cells driven by the cytokine IL-17 play a key role in amplifying the inflammatory response, turning what might have been minor redness into a more aggressive skin reaction.4PubMed Central. Radiation-Induced Dermatitis is Mediated by IL17-Expressing γδ T Cells
The result is a skin barrier that is simultaneously inflamed, understaffed (because replacement cells aren’t being made fast enough), and increasingly fragile. This explains why symptoms tend to worsen steadily as treatment progresses: each new radiation session compounds the damage before the skin has recovered from the last one.
What It Looks and Feels Like
Acute radiation dermatitis typically follows a predictable progression. In its mildest form, the skin turns faintly pink or red, similar to a mild sunburn. As treatments accumulate, the redness deepens, the skin may darken or become noticeably dry and flaky (a stage called dry desquamation), and itching or tenderness sets in. In more severe cases, the outer layer of skin breaks down entirely, creating raw, moist, weeping patches known as moist desquamation. At the extreme end, ulceration can occur.5PubMed. Radiation-Induced Skin Injury: Mechanisms, Clinical Manifestations, and Management
From the patient’s side, the experience is more than cosmetic. A pilot study of breast cancer patients found that nearly all reported symptoms related to radiation dermatitis, with an average of about nine distinct skin problems per person. Hyperpigmentation was the most commonly reported uncomfortable symptom, followed by redness. Patients experiencing dryness, burning feelings, or irritation were many times more likely to say they needed help managing their skin compared to those without those symptoms.6PubMed. Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study And while overall quality of life tends to remain relatively stable during treatment, skin-related quality of life deteriorates steadily over the course of radiotherapy.7PubMed. Longitudinal trends in skin-related and global quality of life among women with breast radiodermatitis: A pilot study
Chronic radiation dermatitis is the long game. Months to years after treatment ends, the irradiated skin may develop lasting changes: visible clusters of tiny blood vessels (telangiectasia), patches of altered pigmentation, thinning or thickening, and scarring-like fibrosis. Hair loss in the treated area can be permanent.8PubMed Central. Dermoscopy of Chronic Radiation-Induced Dermatitis in Patients with Head and Neck Cancers Treated with Radiotherapy These chronic changes tend to be more cosmetically bothersome than physically painful, though fibrosis can restrict movement if the treated area overlies a joint or the chest wall.
Who Gets It Worse
Everyone receiving radiotherapy is at some risk, but certain factors make severe reactions more likely. A systematic review and meta-analysis pooling data from multiple studies identified four patient-related factors that significantly raise the odds of acute radiation dermatitis in breast cancer patients: having a BMI of 25 or higher, having larger breast volume, smoking, and diabetes.9PubMed Central. Risk Factors Related to Acute Radiation Dermatitis in Breast Cancer Patients After Radiotherapy: A Systematic Review and Meta-Analysis Among these, BMI was the most consistently linked to worse outcomes across different study designs. People with diabetes had more than double the relative risk of developing radiation dermatitis compared to those without it.
Treatment-related factors matter too. In breast cancer patients, using a conventional fractionation schedule (smaller daily doses over more sessions) was associated with more moist desquamation than hypofractionated schedules (larger daily doses over fewer sessions). Adding regional lymph node irradiation also increased risk, as did receiving concurrent chemotherapy. For patients who had mastectomies, the use of bolus material (a tissue-equivalent material placed over the skin to boost the surface dose) was the single strongest predictor of moist desquamation, increasing the odds nearly ninefold.10Advances in Radiation Oncology. Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: Role of fractionation and treatment volume
A separate study confirmed the BMI and breast size findings, reporting that patients with medium or large breasts had about 4.6 times the risk of developing grade 2 or higher radiodermatitis compared to those with smaller breasts, and obese patients had roughly 2.9 times the risk compared to those at a normal weight.11PubMed Central. Clinical factors affecting the determination of radiotherapy-induced skin toxicity in breast cancer The reason larger body habitus matters is partly geometric: skin folds create areas of friction and moisture trapping, and larger treatment volumes mean more tissue in the beam path.
Washing the Irradiated Skin
For decades, many radiation therapy centers told patients not to wash the treated skin with soap and water, based on an assumption that washing would irritate already-damaged skin. That advice has been largely overturned. A randomized trial comparing patients who washed normally with soap and water to those who avoided washing found that moist desquamation rates were actually lower in the washing group: 14% versus 33% for those who didn’t wash.12PubMed. The impact of skin washing with water and soap during breast irradiation: a randomized study The explanation is straightforward: gentle washing removes bacteria, dead skin cells, and inflammatory debris that would otherwise compound the irritation.
A systematic review and meta-analysis of randomized trials confirmed these findings, reporting that washing with or without soap significantly cut the odds of both severe radiation dermatitis and moist desquamation.13PubMed. Prevention of radiation dermatitis with skin hygiene and washing: a systematic review and meta-analysis A randomized controlled trial in nasopharyngeal cancer patients further showed that washing delayed the onset of radiation dermatitis and reduced itching. Among the patients in that study, the non-washing group had a severe dermatitis rate of 51%, compared to roughly 20% in both the water-only and soap-and-water groups. Moist desquamation rates were similarly lopsided, and washing with soap and water was the most effective approach for reducing itch and improving quality of life.14PubMed. What is the appropriate skin cleaning method for nasopharyngeal cancer radiotherapy patients? A randomized controlled trial
If you’re currently going through radiation therapy and were told not to wash the treated area, it’s worth raising this with your care team. Current evidence clearly favors gentle washing with mild soap over avoidance.
Preventive Topical Steroids
Applying a topical corticosteroid cream to the treatment area before symptoms become severe is one of the better-supported preventive strategies. A systematic review of randomized controlled trials found that prophylactic topical steroid use significantly reduces the incidence of moist desquamation.15PubMed. Topical corticosteroid therapy for the prevention of acute radiation dermatitis: a systematic review of randomized controlled trials A more recent meta-analysis confirmed this, showing that both betamethasone and mometasone furoate cut the odds of moist desquamation by roughly two-thirds, with betamethasone performing somewhat better.16PubMed. Topical corticosteroids for the prevention of severe radiation dermatitis: a systematic review and meta-analysis
The picture is slightly more nuanced for head and neck cancer patients undergoing concurrent chemoradiation, where the skin reactions tend to be particularly harsh. A randomized, double-blind phase 3 trial found that topical steroids did not significantly reduce the overall rate of grade 2 or higher dermatitis in this group. However, the steroid group had roughly half the rate of the most severe reactions (grade 3 or higher): about 14% versus 26% for placebo.17International Journal of Radiation Oncology, Biology, Physics. Topical Steroid Versus Placebo for the Prevention of Radiation Dermatitis in Head and Neck Cancer Patients Receiving Chemoradiotherapy: A Randomized, Double-Blind, Phase 3 Trial (TOPICS Study) So topical steroids may not prevent all radiation dermatitis, but they appear to keep the worst cases from becoming as bad.
Dressings and Barrier Films
Another preventive option is applying specialized dressings to the irradiated skin. A literature review of modern dressings found that thin film dressings were the most effective for preventing acute radiation dermatitis, while foam dressings performed better for treating existing reactions.18PubMed Central. Modern Dressings in Prevention and Therapy of Acute and Chronic Radiation Dermatitis-A Literature Review The film creates a physical barrier that reduces friction from clothing, maintains moisture balance, and protects the damaged epidermis while it tries to regenerate. Foam dressings, on the other hand, absorb the exudate from moist desquamation and provide a cushion for painful, weeping skin.
Practically speaking, dressings need to be compatible with the daily treatment: they usually have to be removed before each radiation session and reapplied afterward, which can be cumbersome. Many centers use barrier creams or films as a simpler alternative for prevention, reserving absorptive dressings for patients who develop more severe reactions.
How Modern Radiotherapy Techniques Help
Not all radiation is delivered the same way, and the technique used affects how much skin damage occurs. Intensity-modulated radiation therapy (IMRT) sculpts the radiation beam more precisely than conventional techniques, producing a more uniform dose distribution that reduces hot spots in the skin. In breast cancer patients, IMRT significantly lowered the rate of moist desquamation compared to conventional radiation. For patients with large breasts, the difference was particularly dramatic: 48% with IMRT versus 79% with conventional treatment.19PubMed. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer
Even within the IMRT family, delivery methods differ. A phase 3 trial comparing two types of IMRT for breast cancer found that helical tomotherapy (a rotational form of IMRT) produced less erythema and less moist desquamation than a simpler field-in-field IMRT approach: 34% versus 61% for erythema, and 11% versus 33% for moist desquamation.20PubMed. Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy Looking even further ahead, proton therapy, which deposits its energy differently than conventional photon beams, has shown promise in planning studies for reducing the predicted risk of skin toxicity, with modeling suggesting relative risk reductions of up to 70% for some endpoints when the skin surface is actively factored into treatment planning.21PubMed. Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement
Photobiomodulation as a Newer Approach
Photobiomodulation therapy (PBMT), sometimes called low-level laser therapy, involves shining specific wavelengths of light onto the irradiated skin to reduce inflammation and stimulate tissue repair. The idea has gained traction over the past decade, and the evidence so far is cautiously encouraging. A scoping review of 14 studies found that roughly 86% reported positive outcomes from PBMT, with no adverse effects.22PubMed Central. Photobiomodulation therapy for mitigating severity of radiodermatitis in cancer patients undergoing radiotherapy: a scoping review A systematic review and meta-analysis focused on breast cancer patients found that PBMT appeared to prevent the progression to moderate and severe grades of dermatitis, though the certainty of evidence was rated very low.23PubMed. Effectiveness of photobiomodulation therapy in radiation dermatitis: A systematic review and meta-analysis Another meta-analysis concluded that preventive PBMT may protect against severe dermatitis grades and reduce interruptions in radiation treatment.24PubMed Central. Photobiomodulation therapy for the prevention of acute radiation dermatitis: a systematic review and meta-analysis
The honest picture is that most of the available studies are small, and protocols vary widely in terms of light wavelength, dose, and timing. PBMT looks promising enough that larger, standardized trials are underway, but it’s not yet the kind of intervention where you can point to clear consensus guidelines.
Epidermal Growth Factor for Healing
Recombinant human epidermal growth factor (rhEGF) is a protein that promotes cell growth and wound repair, and researchers have been testing whether applying it topically can speed healing in radiation-damaged skin. A self-controlled study in rectal and anal cancer patients found that the side of the treatment field receiving rhEGF developed significantly smaller areas of radiation dermatitis compared to the untreated control side.25PubMed Central. The effect of recombinant human epidermal growth factor on radiation dermatitis in rectal and anal cancer patients: a self-controlled study For patients who already have severe weeping reactions, foam dressings soaked with rhEGF have shown rapid healing times in head and neck cancer patients, with a median of about eight days to complete re-epithelialization.26PubMed Central. Foam dressing with epidermal growth factor for severe radiation dermatitis in head and neck cancer patients Animal research has additionally suggested that rhEGF can not only repair radiation wounds but also reduce the likelihood of the dermatitis recurring.27Journal of Radiation Research. The Preventive Effect of Recombinant Human Growth Factor (rhEGF) on the Recurrence of Radiodermatitis
These findings are intriguing but still relatively early-stage. Most studies are small, and rhEGF isn’t widely available as a standard-of-care product in many countries. It’s worth knowing about, especially for patients dealing with stubborn, non-healing wounds after radiotherapy.
Why Severe Reactions Might Start with the Skin Microbiome
One of the more surprising recent discoveries involves the bacteria living on the skin surface. A study published in JAMA Oncology tracked the skin microbiome of breast cancer patients throughout their radiation treatment and found that patients who went on to develop severe radiodermatitis had a distinctive pattern: they started with fewer protective commensal bacteria at baseline, and then experienced an overgrowth of total bacterial load in the first few weeks of treatment, before clinical symptoms even appeared.28JAMA Oncology. Association of Skin Microbiome Dynamics With Radiodermatitis in Patients With Breast Cancer The implication is that certain patients may be predisposed to severe reactions in part because their skin’s microbial ecosystem is already compromised before treatment begins.
A separate study went further, identifying specific bacterial species that were enriched in patients with moderate-to-severe radiation dermatitis. Patients who harbored at least two out of three particular bacterial species had roughly 12 times the odds of developing moderate or severe dermatitis compared to those who didn’t carry those organisms.29Clinical and Translational Radiation Oncology. Characterization of skin microbiome profile before and during radiation therapy and its correlation to the occurrence and severity of radiation dermatitis This raises the tantalizing possibility that microbiome profiling before treatment could one day identify high-risk patients, and that interventions targeting skin bacteria — whether through targeted antimicrobials or probiotics — might prevent severe reactions. The research is still early, but it represents a fundamentally different way of thinking about why some people’s skin breaks down under radiation and others’ doesn’t.
Long-Term Skin Cancer Risk in Irradiated Areas
Beyond the acute and chronic skin changes, there is a long-term concern that irradiated skin carries an elevated risk of developing new skin cancers, particularly basal cell carcinoma (BCC). A study of patients previously treated with radiation therapy for various conditions found that radiation exposure was associated with about a 1.7-fold higher risk of developing a first new BCC, while the risk of squamous cell carcinoma was not increased. The total tumor risk for BCC was even higher, at roughly 2.3 times baseline. The risk appeared to be greater in patients who were younger at the time of exposure and increased with the number of years since treatment.30PubMed. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy
The risk is much more dramatic in children. A report from the Childhood Cancer Survivor Study found that childhood cancer survivors who received 35 Gy or more of radiation to a given skin site had nearly 40 times the odds of developing BCC at that site compared to survivors who received no radiation therapy. The relationship followed a linear dose-response pattern.31JNCI: Journal of the National Cancer Institute. Radiation-Related Risk of Basal Cell Carcinoma: A Report From the Childhood Cancer Survivor Study This is an important consideration for long-term cancer survivorship care: irradiated skin areas should be examined periodically by a dermatologist, especially in people who received radiation as children or young adults.
When Radiation Wounds Won’t Heal
Severe radiation dermatitis sometimes extends far beyond treatment itself. Rare cases involve chronic non-healing ulcers or skin necrosis that persists for months or years. Severe reactions can also delay or interrupt the radiation treatment course, which has implications for cancer control.32PubMed Central. Radiation-induced skin reactions: mechanism and treatment For refractory wounds, hyperbaric oxygen therapy has emerged as a potential option. By having patients breathe pure oxygen in a pressurized chamber, the treatment drives more oxygen into the damaged tissue, supporting new blood vessel growth and wound repair. A systematic review found that hyperbaric oxygen therapy is safe and shows promising results for radiation-induced skin necrosis, though the evidence base remains limited.33PubMed. Systematic review of hyperbaric oxygen therapy for the treatment of radiation-induced skin necrosis One case report described successful treatment of a radiation-induced skin ulcer with more than 100 hyperbaric oxygen sessions in a patient whose irradiated skin was too fragile for surgical repair.34PubMed Central. Hyperbaric oxygen therapy for a refractory skin ulcer after radical mastectomy and radiation therapy: a case report
Hyperbaric oxygen remains a niche treatment: it requires specialized facilities, is time-intensive, and is typically reserved for cases where other options have been exhausted. But for patients stuck in a cycle of non-healing radiation wounds, it represents a real alternative to surgical reconstruction.